PARTNERS FOR GROWTH
Aspen Capital Group is a growth equity firm that partners with founders and entrepreneurs to build industry-leading technology and tech-enabled services businesses

Aspen Capital Group takes great pride in helping our partner companies build leading businesses that will succeed for years to come

Aspen Capital Group focuses on partnering with founders and entrepreneurs to help them execute on their companies’ growth strategies. We maintain a long-term investment horizon that focuses on maximizing the value creation potential of each partner company. Our unique capital base allows for significant flexibility in structuring and determining the hold period for each investment.

Learn More

Long-term Perspective

We have a successful track record of partnering with companies to drive long-term growth.

Value Creation

We focus on identifying and continuously driving towards key initiatives to achieve and maintain market leadership.

Aspen Capital Group strategic partnerships

Strategic Partnerships

We help companies assemble world class Boards of Directors, Executive Teams and Strategic Partners.

How We Add Value

“Aspen Capital has been a true partner for us. They came with a strong understanding of our business as well as the insurance landscape and added value even before their investment closed. They introduced new sales channels, worked hand-in-hand helping refine our GTM approach and have been thought partners every step of the way. Aspen even introduced us to marquee channel partners that significantly advanced our business development function which is now responsible for our largest and most impactful revenue opportunities. The Aspen team has a great balance of operational and investing experience and we are thrilled to have them as partners.”

Gary Hagmueller - CEO, CLARA Analytics

“Steve Jones of Aspen Capital was instrumental in the growth and development of NeoGenomics. Aspen closed its first investment in 2003 and continued to invest for years as the Company required growth capital. In addition, Steve was deeply involved in helping NeoGenomics refine its business model and strategy, and execute many strategic initiatives. Today, NeoGenomics is a recognized leader in Oncology Diagnostics with a market capitalization over $5 billion and Steve remains a trusted member of our Board.”

Douglas VanOort - Chairman and CEO, NeoGenomics, Inc. (NASDAQ: NEO)

Press Releases

Aclaimant raises $15 million in Series B financing 150 150 Aspen Capital Group

Aclaimant raises $15 million in Series B financing

CHICAGO – Aclaimant, an insight-driven workflow platform for safety and risk management, today announced it has raised $15 million in Series B equity and debt funding led by Next Coast Ventures. This brings the company’s total funds raised to over $20 million. Adam Rogers, former CEO of Ultimate Software, and existing investors Mercury Fund, KEC Ventures, Royal Street Ventures, and Aspen Capital Group also participated in…

read more
Deposco Secures $35 Million in New Growth Funding 150 150 Aspen Capital Group

Deposco Secures $35 Million in New Growth Funding

ALPHARETTA, Ga., – Deposco, the leading provider of cloud-based omnichannel fulfillment software solutions, today announced the closing of a $35 million investment round led by NewSpring, with participation from Aspen Capital Group and existing investors. The investment validates Deposco’s team and technology, as fulfillment has evolved into an essential part of the brand experience for retailers and consumer…

read more
Aclaimant raises $10 million in Series A financing to accelerate workplace safety 150 150 Aspen Capital Group

Aclaimant raises $10 million in Series A financing to accelerate workplace safety

CHICAGO, June 29, 2020 — Aclaimant, an insight-driven workflow platform for safety and risk management, today announced it has raised $10 million in Series A funding led by Mercury Fund. This brings the company’s total funds raised to nearly $13 million, with a seed round of $2.9 million secured in 2017. Additional investors for the Series A financing include Royal Street Ventures, EBSCO Capital, KEC Ventures, RRE…

read more
CLARA analytics Raises $25M in Series B Funding 150 150 Aspen Capital Group

CLARA analytics Raises $25M in Series B Funding

SANTA CLARA, Calif.  — CLARA analytics (“CLARA”), the leading provider of artificial intelligence (AI) technology in the commercial insurance industry, today announced that it closed $25 million in Series B funding, bringing its total funding to $36.5 million. The round was led by growth equity firm Aspen Capital Group with participation from Series A lead Oak HC/FT and additional investors. CLARA…

read more
  • 1
  • 2
WHO WE ARE

Aspen Capital TM  is a growth equity firm that partners with founders and entrepreneurs to build industry-leading technology and tech-enabled services businesses.

Stay Connected

Email: Info@aspencapgroup.com
Phone: (239) 325-2002

© 2021 All rights reserved Aspen Capital TM. Website Design by The New York Website Designer

Enter your
text here